Madison, WI, December 14, 2012 --(PR.com
)-- Cresa Madison represented PharmaSeek in negotiating their office expansion at 8476 Greenway Boulevard in Middleton. PharmaSeek has outgrown their 2,900 square foot space and will occupy 7,000 square feet beginning January 15th, 2013.
Having worked with PharmaSeek in 2010, Cresa Madison was reengaged to help the company secure a real estate solution that would accommodate their growth. “PharmaSeek is pleased to be working with Cresa again. Cresa did an excellent job negotiating the terms of our expansion,” stated Nicolas Cindric, PharmaSeek’s Chief Executive Officer.
PharmaSeek works with Sponsors and CROs to identify sites for clinical trials with the goal of connecting quality clinical research studies with experienced, high performing research sites. Founded in 1994, PharmaSeek has grown into a network of 250 sites located throughout the United States, Canada, Mexico and the Caribbean.
Cresa is an international corporate real estate advisory firm that exclusively represents tenants and specializes in the delivery of fully integrated real estate services, including: Transaction Management, Project Management, Global Accounts, Portfolio Strategies, Location Planning, Lease Administration, Capital Markets, and Facilities Services. With more than 57 offices, Cresa is the largest tenant representation firm in North America. Through its partnership with Savills, one of the world’s largest commercial real estate services firms; Cresa covers more than 255 locations in 40 countries. For more information, visit www.cresa.com.
PharmaSeek is an Investigative Site Network (ISN) that specializes in expediting clinical trials to a successful completion. PharmaSeek accelerates the complex process of securing investigative sites for Phase I through Phase IV clinical trials. Effective site selection and patient recruitment can streamline the approval of a drug or device and get it to market quickly. Pairing clinical studies with appropriate sites is critical to achieving successful results. More information can be found at www.pharmaseek.com